These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23651541)

  • 21. Social support, disclosure and stigma and the association with non-adherence in the six months after antiretroviral therapy initiation among a cohort of HIV-positive adults in rural KwaZulu-Natal, South Africa
    George S; McGrath N
    AIDS Care; 2019 Jul; 31(7):875-884. PubMed ID: 30472889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.
    Ssebunya R; Wanyenze RK; Lukolyo H; Mutto M; Kisitu G; Amuge P; Maganda A; Kekitiinwa A
    BMC Infect Dis; 2017 Jun; 17(1):439. PubMed ID: 28629459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.
    Oyugi JH; Byakika-Tusiime J; Ragland K; Laeyendecker O; Mugerwa R; Kityo C; Mugyenyi P; Quinn TC; Bangsberg DR
    AIDS; 2007 May; 21(8):965-71. PubMed ID: 17457090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015.
    Bulage L; Ssewanyana I; Nankabirwa V; Nsubuga F; Kihembo C; Pande G; Ario AR; Matovu JK; Wanyenze RK; Kiyaga C
    BMC Infect Dis; 2017 May; 17(1):326. PubMed ID: 28468608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options.
    Baumann A; Musaazi J; Kambugu A; Kälin M; Weissberg D; Ssemwanga D; Fehr J; Castelnuovo B; Sekaggya-Wiltshire C; von Braun A
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):481-487. PubMed ID: 30633041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
    Hunt PW; Cao HL; Muzoora C; Ssewanyana I; Bennett J; Emenyonu N; Kembabazi A; Neilands TB; Bangsberg DR; Deeks SG; Martin JN
    AIDS; 2011 Nov; 25(17):2123-31. PubMed ID: 21881481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study.
    Homsy J; Bunnell R; Moore D; King R; Malamba S; Nakityo R; Glidden D; Tappero J; Mermin J
    PLoS One; 2009; 4(1):e4149. PubMed ID: 19129911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda.
    Weiser SD; Palar K; Frongillo EA; Tsai AC; Kumbakumba E; Depee S; Hunt PW; Ragland K; Martin J; Bangsberg DR
    AIDS; 2014 Jan; 28(1):115-20. PubMed ID: 23939234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.
    Spire B; Carrieri P; Sopha P; Protopopescu C; Prak N; Quillet C; Ngeth C; Ferradini L; Delfraissy JF; Laureillard D
    Antivir Ther; 2008; 13(5):697-703. PubMed ID: 18771053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Patient-Selected Care Buddies on Adherence to HIV Care, Disease Progression, and Conduct of Daily Life Among Pre-antiretroviral HIV-Infected Patients in Rakai, Uganda: A Randomized Controlled Trial.
    Nakigozi G; Makumbi FE; Bwanika JB; Atuyambe L; Reynolds SJ; Kigozi G; Nalugoda F; Chang LW; Kiggundu V; Serwadda D; Wawer MJ; Gray RH; Kamya MR
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):75-82. PubMed ID: 26039929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.
    Tukei VJ; Murungi M; Asiimwe AR; Migisha D; Maganda A; Bakeera-Kitaka S; Kalyesubula I; Musoke P; Kekitiinwa A
    BMC Pediatr; 2013 Mar; 13():42. PubMed ID: 23536976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda.
    Matthews LT; Orrell C; Bwana MB; Tsai AC; Psaros C; Asiimwe S; Amanyire G; Musinguzi N; Bell K; Bangsberg DR; Haberer JE;
    J Int AIDS Soc; 2020 Aug; 23(8):e25586. PubMed ID: 32820622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa.
    Vreeman RC; Ayaya SO; Musick BS; Yiannoutsos CT; Cohen CR; Nash D; Wabwire D; Wools-Kaloustian K; Wiehe SE
    PLoS One; 2018; 13(2):e0191848. PubMed ID: 29466385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
    Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
    J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.
    Shet A; Kumarasamy N; Poongulali S; Shastri S; Kumar DS; Rewari BB; Arumugam K; Antony J; De Costa A; D'Souza G
    Curr HIV Res; 2016; 14(1):71-9. PubMed ID: 26303008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of disclosure of HIV status on patient representation and adherence to clinic visits in eastern Uganda: A propensity-score matched analysis.
    Izudi J; Okoboi S; Lwevola P; Kadengye D; Bajunirwe F
    PLoS One; 2021; 16(10):e0258745. PubMed ID: 34665842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
    Thirumurthy H; Ndyabakira A; Marson K; Emperador D; Kamya M; Havlir D; Kwarisiima D; Chamie G
    Lancet HIV; 2019 Mar; 6(3):e155-e163. PubMed ID: 30660594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reasons for Missing Antiretroviral Therapy: Results from a Multi-Country Study in Tanzania, Uganda, and Zambia.
    Koole O; Denison JA; Menten J; Tsui S; Wabwire-Mangen F; Kwesigabo G; Mulenga M; Auld A; Agolory S; Mukadi YD; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Bangsberg DR; Colebunders R
    PLoS One; 2016; 11(1):e0147309. PubMed ID: 26788919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.